UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells

Blood, 2006-10, Vol.108 (8), p.2608-2615

2006

Volltextzugriff (PDF)

Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes

The FASEB journal, 2008-12, Vol.22 (12), p.4146-4153

2008

Volltextzugriff (PDF)

Synthesis of thrombin-inhibiting heparin mimetics without side effects

Nature (London), 1999-04, Vol.398 (6726), p.417-422

1999

Volltextzugriff (PDF)

Contribution of erythrocytes to thrombin generation in whole blood

Thrombosis and haemostasis, 1999-03, Vol.81 (3), p.400

1999

Volltextzugriff (PDF)

SR123781A, a synthetic heparin mimetic

Thrombosis and haemostasis, 2001-05, Vol.85 (5), p.852

2001

Volltextzugriff (PDF)

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy

Journal of thrombosis and haemostasis, 2008-10, Vol.6 (10), p.1697-1706

2008

Volltextzugriff (PDF)

The effect of the synthetic pentasaccharide SR 90107/ORG 31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa

Thrombosis and haemostasis, 1995, Vol.74 (6), p.1474

1995

Volltextzugriff (PDF)

Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo

Thrombosis and haemostasis, 1998-02, Vol.79 (2), p.383

1998

Volltextzugriff (PDF)

Biochemical and Pharmacological Properties of SANORG 32701: Comparison With the `Synthetic Pentasaccharide' (SR 90107/ORG 31540) and Standard Heparin

Circulation research, 1996-09, Vol.79 (3), p.590-600

1996

Volltextzugriff (PDF)

Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis

Journal of thrombosis and haemostasis, 2004-06, Vol.2 (6), p.925-930

2004

Volltextzugriff (PDF)

The structure of synthetic oligosaccharides in relation to factor IXa inhibition

Thrombosis and haemostasis, 2002-09, Vol.88 (3), p.432

2002

Volltextzugriff (PDF)

Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats

Thrombosis and haemostasis, 2002-02, Vol.87 (2), p.238

2002

Volltextzugriff (PDF)

Anti-thrombotic effect of a synthetic heparin mimetic in an arterial model of thrombosis in rats: comparison with unfractionated heparin and nadroparin

Thrombosis and haemostasis, 2002-10, Vol.88 (4), p.687

2002

Volltextzugriff (PDF)

Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats

Thrombosis and haemostasis, 2000-10, Vol.84 (4), p.668

2000

Volltextzugriff (PDF)

Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors

Biochemical pharmacology, 1999-03, Vol.57 (6), p.603-610

1999

Volltextzugriff (PDF)

Comparative inhibition of extrinsic and intrinsic thrombin generation by standard heparin, a low molecular weight heparin and the synthetic ATIII-binding pentasaccharide

Thrombosis and haemostasis, 1993, Vol.69 (2), p.152

1993

Volltextzugriff (PDF)

Effects of a new platelet glycoprotein IIb/IIIa antagonist, SR121566, on platelet activation, platelet-leukocyte interaction and thrombin generation

Blood coagulation & fibrinolysis, 1998-09, Vol.9 (6), p.507-516

1998

Volltextzugriff (PDF)

Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat

Thrombosis and haemostasis, 1999-06, Vol.81 (6), p.957

1999

Volltextzugriff (PDF)

Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2

Arteriosclerosis, thrombosis, and vascular biology, 2000-11, Vol.20 (11), p.E107

2000

Volltextzugriff (PDF)

Life-Threatening Thrombosis in Mice With Targeted Arg48-to-Cys Mutation of the Heparin-Binding Domain of Antithrombin

Circulation research, 2003-11, Vol.93 (11), p.1120-1126

2003

Volltextzugriff (PDF)

Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot‐bound thrombin and factor Xa in vitro and in vivo

Journal of thrombosis and haemostasis, 2003-09, Vol.1 (9), p.1959-1965

2003

Volltextzugriff (PDF)

Comparative effects of two synthetic oligosaccharides on platelet activation induced by plasma from HIT patients

Journal of thrombosis and haemostasis, 2003-09, Vol.1 (9), p.2008-2013

2003

Volltextzugriff (PDF)

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy

Journal of thrombosis and haemostasis, 2008-10, Vol.6 (10), p.1697-1706

2008

Volltextzugriff (PDF)

DETERMINATION OF THE ANTI-FACTOR Xa ACTIVITY OF THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 AND OF TWO STRUCTURAL ANALOGUES

Thrombosis research, 1997, Vol.85 (1), p.67-75

1997

Volltextzugriff (PDF)

THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 DOES NOT RELEASE LIPASE ACTIVITY INTO THE PLASMA

Thrombosis research, 1997-05, Vol.86 (4), p.325-332

1997

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(81)
Humans
(65)
Biological And Medical Sciences
(51)
Medical Sciences
(39)
Animals
(31)
Hematology
(30)
Male
(29)
Pharmacology. Drug Treatments
(28)
Physical Sciences
(26)
Blood. Blood Coagulation. Reticuloendothelial System
(23)
Factor Xa Inhibitors
(22)
Cardiovascular System & Cardiology
(21)
Peripheral Vascular Disease
(21)
Female
(19)
Molecular Sequence Data
(19)
Oligosaccharides - Pharmacology
(17)
Physics
(15)
Rats
(15)
Carbohydrate Sequence
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells

Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes

Synthesis of thrombin-inhibiting heparin mimetics without side effects

Contribution of erythrocytes to thrombin generation in whole blood

SR123781A, a synthetic heparin mimetic

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy

The effect of the synthetic pentasaccharide SR 90107/ORG 31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa

Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo

Biochemical and Pharmacological Properties of SANORG 32701: Comparison With the `Synthetic Pentasaccharide' (SR 90107/ORG 31540) and Standard Heparin

Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis

The structure of synthetic oligosaccharides in relation to factor IXa inhibition

Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats

Anti-thrombotic effect of a synthetic heparin mimetic in an arterial model of thrombosis in rats: comparison with unfractionated heparin and nadroparin

Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats

Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors

Comparative inhibition of extrinsic and intrinsic thrombin generation by standard heparin, a low molecular weight heparin and the synthetic ATIII-binding pentasaccharide

Effects of a new platelet glycoprotein IIb/IIIa antagonist, SR121566, on platelet activation, platelet-leukocyte interaction and thrombin generation

Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat

Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2

Life-Threatening Thrombosis in Mice With Targeted Arg48-to-Cys Mutation of the Heparin-Binding Domain of Antithrombin

Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot‐bound thrombin and factor Xa in vitro and in vivo

Comparative effects of two synthetic oligosaccharides on platelet activation induced by plasma from HIT patients

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy

DETERMINATION OF THE ANTI-FACTOR Xa ACTIVITY OF THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 AND OF TWO STRUCTURAL ANALOGUES

THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 DOES NOT RELEASE LIPASE ACTIVITY INTO THE PLASMA

Suchergebnisse filtern